Yanggu Huatai(SZ:300121) Zheng Quan Zhi Xing·2025-08-13 16:23Core Viewpoint - Shandong Yanggu Huatai Chemical Co., Ltd. plans to issue shares and pay cash to acquire 99.64% of the equity of Bomi Technology Co., Ltd. and raise supporting funds through a related party transaction [1][6]. Summary by Sections Transaction Details - The transaction involves the purchase of assets from multiple parties, including Hainan Juxin, Wang Chuanhua, Wu Fengyun, and others [1]. - The company intends to raise funds from no more than 35 specific investors as per the regulations of the China Securities Regulatory Commission [1]. Financial and Legal Commitments - The company and its board members guarantee the accuracy and completeness of the restructuring report and its summary, assuming legal responsibility for any false statements or omissions [2][3]. - The controlling shareholders and actual controllers commit to not transferring their shares during the investigation period if any information provided is found to be misleading or false [2][5]. Regulatory Compliance - The restructuring report does not represent any substantive judgment or approval from the China Securities Regulatory Commission or the Shenzhen Stock Exchange [3]. - The effectiveness and implementation of the transaction are subject to the approval of regulatory authorities [3]. Adjustments to the Restructuring Plan - The company held board meetings to approve adjustments to the restructuring plan, including changes to the parties involved in the transaction [11][12]. - The performance commitment period for the transaction is set for four consecutive accounting years starting from the year of completion, with specific profit targets outlined for the years 2025 and 2026 [13][14].